DB-772D administered in 4 different formulations

• Research type

  Research Study

• Full title

  An open-label, randomised, four-sequence, eight-period cross-over single oral dose study to investigate the bioavalibility and effect of food on the pharmacokinetics of DB-772D administered as three extended release formulations and a solution in healthy male and female subjects

• IRAS ID

  36727

• Sponsor organisation

  North Manchester Clinical Commissioning Group

• Eudract number

  2009-015996-28

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  N/A

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  09/IEC04/2

• Date of REC Opinion

  3 Dec 2009

• REC opinion

  Further Information Favourable Opinion